We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

179 hedge funds and large institutions have $1.81B invested in Acorda Therapeutics in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $5.04M

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

19% more capital invested

Capital invested by funds: $1.52B → $1.81B (+$293M)

3% more funds holding

Funds holding: 174 → 179 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 68

Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
4.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
55
Reduced
68
Closed
20
Calls
$12.9M
Puts
$5.04M
Net Calls
+$7.88M
Net Calls Change
+$2.93M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$18.8M
2
VAM
Visium Asset Management
New York
+$18.7M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.86M
4
Charles Schwab
Charles Schwab
California
+$7.87M
5
BFA
BlackRock Fund Advisors
California
+$7.82M

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$29.3M
2
PHS
PFM Health Sciences
California
-$12.6M
3
MACM
March Altus Capital Management
Connecticut
-$10.3M
4
PCM
Penn Capital Management
Pennsylvania
-$9.32M
5
RFC
Russell Frank Company
Washington
-$6.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$16.5M +$1.09M +255 +8%
Jennison Associates
27
Jennison Associates
New York
$16.2M -$833K -194 -6%
BA
28
BlackRock Advisors
Delaware
$14.4M -$129K -30 -1%
Charles Schwab
29
Charles Schwab
California
$14.4M +$7.87M +1,834 +166%
TA
30
Teachers Advisors
New York
$13.5M +$738K +172 +7%
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$12.7M +$68.7K +16 +0.6%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$11.6M +$124K +29 +1%
TCM
33
Tekla Capital Management
Massachusetts
$11.2M – – –
Principal Financial Group
34
Principal Financial Group
Iowa
$10.7M +$77.2K +18 +0.8%
AG
35
Artal Group
Luxembourg
$10.2M – – –
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$10.1M +$8.86M +2,065 New
Macquarie Group
37
Macquarie Group
Australia
$8.92M +$1.22M +285 +19%
TCIM
38
TIAA CREF Investment Management
New York
$8.82M -$107K -25 -1%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$8.75M -$858K -200 -10%
Bank of America
40
Bank of America
North Carolina
$8.41M -$21.5K -5 -0.3%
Ameriprise
41
Ameriprise
Minnesota
$8.01M +$4.29K +1 +0.1%
UBS Group
42
UBS Group
Switzerland
$7.71M +$6.75M +1,573 New
Goldman Sachs
43
Goldman Sachs
New York
$7.62M -$1.78M -415 -21%
Millennium Management
44
Millennium Management
New York
$6.92M -$4.09M -954 -40%
MAA
45
Managed Account Advisors
New Jersey
$6.66M +$549K +128 +10%
GAM
46
Gotham Asset Management
New York
$6.61M +$395K +92 +7%
American Century Companies
47
American Century Companies
Missouri
$6.58M +$4.55M +1,061 +378%
PAM
48
Panagora Asset Management
Massachusetts
$6.49M +$68.7K +16 +1%
Prudential Financial
49
Prudential Financial
New Jersey
$6.39M -$167K -39 -3%
ACMM
50
Arbor Capital Management (Minnesota)
Minnesota
$6.29M +$5.51M +1,284 New
1
2
3 4 5

ACOR Hedge Fund Activity: Q4 2014 in Review

179 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2014, worth a combined $1.81B — up 19% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 20 closed out — a net gain of 6 holders — while 55 added to existing stakes and 68 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $18.8M. The largest seller was Oracle Investment Management, cutting an estimated $29.3M.

  • 179 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2014, up from 174 in Q3 2014.
  • Funds reported $1.81B of Acorda Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q4 2014 and 20 closed out, a net change of +6 holders.
  • The largest Acorda Therapeutics buyer in Q4 2014 was Wellington Management Group, an estimated $18.8M added.
  • The largest Acorda Therapeutics seller in Q4 2014 was Oracle Investment Management, an estimated $29.3M sold.

Based on aggregated 13F filings for Q4 2014.